Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,969,231
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
1,942,445
-
Shares change
-
+215,516
-
Total reported value, excl. options
-
$37,703,608
-
Value change
-
+$4,889,864
-
Put/Call ratio
-
98.22%
-
Number of buys
-
24
-
Number of sells
-
-14
-
Price
-
$19.42
Significant Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q3 2021
54 filings reported holding INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,942,445 shares
of 27,969,231 outstanding shares and own 6.94% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (448,911 shares), ACT Capital, L.L.C. (275,000 shares), BlackRock Inc. (146,429 shares), ROYAL BANK OF CANADA (126,411 shares), MILLENNIUM MANAGEMENT LLC (123,511 shares), DEUTSCHE BANK AG\ (106,048 shares), Janney Montgomery Scott LLC (99,323 shares), GEODE CAPITAL MANAGEMENT, LLC (89,607 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (82,529 shares), and MARSHALL WACE, LLP (64,650 shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.